大隐静脉动脉化用于无法重建外周动脉疾病的保肢长期结果
本研究回顾了2019至2024年间15例无法重建的慢性肢体威胁性缺血患者共20条肢体接受大隐静脉动脉化(GSVA)的结果。GSVA联合足部静脉瓣膜破坏为无法重建的CLTI患者提供了一种可行的保肢选择。
要点
- GSVA技术成功率高,无重大手术并发症。
- 12个月免于膝下截肢生存率为53%。
- 未截肢肢体中91%实现伤口愈合和疼痛改善。
核心结论
- GSVA联合足部静脉瓣膜破坏为无法重建的CLTI患者提供可行的保肢选择,1年免于膝下截肢生存率超过50%且伤口愈合显著。
研究设计与样本
- 回顾性队列研究,纳入2019年10月至2024年8月间15例无法重建的CLTI患者共20条肢体,均接受GSVA。
主要发现
- 12个月随访时,19条肢体中免于膝下截肢生存率为53%(10/19)。
- 总随访期间,20条肢体中免于膝下截肢生存率为55%(11/20)。
- 未截肢肢体中91%显示伤口愈合和疼痛改善。
- 大多数截肢(8/9)发生在GSVA术后1.5个月内。
临床怎么用
- 对于无法进行常规血运重建的CLTI患者,可考虑GSVA联合足部静脉瓣膜破坏作为保肢手段。
局限性
- 样本量小(15例患者20条肢体),需更大规模研究优化患者选择和 outcomes。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic limb-threatening ischemia (CLTI) is the end stage of peripheral arterial disease, characterized by ischemic rest pain, nonhealing ulcers, or gangrene. Up to 40% of patients lack distal targets for revascularization, often resulting in major amputation. Great saphenous vein arterialization (GSVA) with distal pedal vein valve disruption is a promising limb salvage technique. We report 12-month amputation, pain, and wound healing for patients with CLTI treated with GSVA between 2019 and 2024. METHODS: From October 2019 to August 2024, 20 limbs in 15 patients with unreconstructable CLTI underwent GSVA. The GSV was used in situ and anastomosed to the most distal patent artery, with central valvulotomy and peripheral valve disruption. Outcomes were assessed through chart review on August 2025. RESULTS: GSVA was technically successful in all cases without major operative complications. Patients were predominantly male (87%) with mean age 63 years; 87% had diabetes. Follow-up of ≥12 months was available for 14 of 15 patients (19 of 20 limbs). One patient died 327 days post-GSVA without undergoing amputation. Among the 19 limbs with 12-month follow-up, below knee amputation (BKA)-free survival was 53% (10 of 19). Over total study follow-up, BKA-free survival was 55% (11 of 20). In limbs without BKA, 91% demonstrated wound healing and pain improvement. Most amputations (8 of 9) occurred within 1.5 months of GSVA. CONCLUSION: GSVA with pedal valve disruption offers a viable limb salvage option for patients with unreconstructable CLTI, achieving >50% BKA-free survival at 1 year and substantial wound healing. Larger studies are needed to refine patient selection and optimize outcomes.
引用
- Shoemaker H, Lau DL, Safran BA, et al. Saphenous Vein Arterialization for Limb Salvage in Unreconstructable Peripheral Arterial Disease: Long-Term Results. Ann Vasc Surg. 2026. PMID: 41895601. doi:10.1016/j.avsg.2026.03.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。